Substance / Medication

Ritlecitinib tosylate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Predictors and mechanisms of self-stigma in five chronic skin diseases: A systematic review.
Stuhlmann Caroline F Z, Traxler Juliane, Paucke Valentina et al. · J Eur Acad Dermatol Venereol · 2025
PMID: 39247975Meta-AnalysisFull text (PMC)
Association Between Serum Trace Elements Level and Alopecia Areata: A Systematic Review and Meta-Analysis.
Wu Ruiying, Li Yuanwen, Peng Hongye et al. · J Cosmet Dermatol · 2025
PMID: 39739356Meta-AnalysisFull text (PMC)
The Role of Reactive Oxygen Species in the Pathogenesis of Alopecia Areata: A Systematic Review and Meta-Analysis.
Perlmutter Jonah, Akouris Polycronis P, Fremont Sierra et al. · Skin Pharmacol Physiol · 2025
PMID: 39746345Meta-Analysis
Skin image analysis for detection and quantitative assessment of dermatitis, vitiligo and alopecia areata lesions: a systematic literature review.
Kallipolitis Athanasios, Moutselos Konstantinos, Zafeiriou Argyriοs et al. · BMC Med Inform Decis Mak · 2025
PMID: 39780145Meta-AnalysisFull text (PMC)
Familial patterns of alopecia areata: A systematic review and meta-analysis.
Huang Yuwei, Jee Eunjin, Kim Minkyu et al. · J Autoimmun · 2025
PMID: 39919410Meta-Analysis
Off-label use of JAK1 inhibitor upadacitinib in dermatology.
Zhang Tian-Yi, Zeng Yue-Ping · Arch Dermatol Res · 2025
PMID: 39920358Meta-Analysis
Inflammatory Nail Disorders in Skin of Color: A Systematic Review of Clinical and Onychoscopic Manifestations.
Tordjman Lea, Thomas Jason, Tosti Antonella et al. · Int J Dermatol · 2025
PMID: 39934092Meta-AnalysisFull text (PMC)
Alopecia Areata-Specific Patient-Reported Outcome Measures: A Systematic Review.
Darchini-Maragheh Emadodin, Moussa Anthony, Yoong Nicole et al. · JAMA Dermatol · 2025
PMID: 40042834Meta-Analysis
Off-Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives.
Spadafora Marco, Morsia Serena, Di Lernia Vito Giuseppe et al. · Exp Dermatol · 2025
PMID: 40192197Meta-AnalysisFull text (PMC)
Ritlecitinib Tosylate.
Am J Health Syst Pharm · 2023
PMID: 37703124Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ritlecitinib tosylate (substance)
SNOMED CT
42476811000001107
UMLS CUI
C5827146

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.